vs
Side-by-side financial comparison of Lucid Diagnostics Inc. (LUCD) and MOBIX LABS, INC (MOBX). Click either name above to swap in a different company.
MOBIX LABS, INC is the larger business by last-quarter revenue ($1.9M vs $1.2M, roughly 1.5× Lucid Diagnostics Inc.). MOBIX LABS, INC runs the higher net margin — -540.0% vs -858.5%, a 318.5% gap on every dollar of revenue. On growth, Lucid Diagnostics Inc. posted the faster year-over-year revenue change (3.3% vs -40.8%). Over the past eight quarters, MOBIX LABS, INC's revenue compounded faster (28.0% CAGR vs 7.9%).
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.
LUCD vs MOBX — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.2M | $1.9M |
| Net Profit | $-10.4M | $-10.1M |
| Gross Margin | — | 31.0% |
| Operating Margin | -971.0% | -471.1% |
| Net Margin | -858.5% | -540.0% |
| Revenue YoY | 3.3% | -40.8% |
| Net Profit YoY | 16.0% | 49.0% |
| EPS (diluted) | $-0.10 | $-0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.9M | ||
| Q3 25 | $1.2M | $1.9M | ||
| Q2 25 | $1.2M | $2.4M | ||
| Q1 25 | $828.0K | $2.5M | ||
| Q4 24 | $1.2M | $3.2M | ||
| Q3 24 | $1.2M | $3.0M | ||
| Q2 24 | $976.0K | $2.1M | ||
| Q1 24 | $1.0M | $1.1M |
| Q4 25 | — | $-10.1M | ||
| Q3 25 | $-10.4M | $-15.7M | ||
| Q2 25 | $-4.4M | $-8.3M | ||
| Q1 25 | $-26.9M | $-2.3M | ||
| Q4 24 | $-11.5M | $-19.8M | ||
| Q3 24 | $-12.4M | $-11.5M | ||
| Q2 24 | $-11.0M | $-7.7M | ||
| Q1 24 | $-10.6M | $-1.8M |
| Q4 25 | — | 31.0% | ||
| Q3 25 | — | 50.5% | ||
| Q2 25 | — | 57.4% | ||
| Q1 25 | — | 40.6% | ||
| Q4 24 | — | 53.2% | ||
| Q3 24 | — | 56.6% | ||
| Q2 24 | — | 35.5% | ||
| Q1 24 | — | 16.9% |
| Q4 25 | — | -471.1% | ||
| Q3 25 | -971.0% | -834.9% | ||
| Q2 25 | -978.8% | -343.4% | ||
| Q1 25 | -1508.1% | -311.7% | ||
| Q4 24 | -1033.8% | -461.7% | ||
| Q3 24 | -997.8% | -378.0% | ||
| Q2 24 | -1146.7% | -454.2% | ||
| Q1 24 | -1078.1% | -747.8% |
| Q4 25 | — | -540.0% | ||
| Q3 25 | -858.5% | -835.8% | ||
| Q2 25 | -381.7% | -352.0% | ||
| Q1 25 | -3249.8% | -91.2% | ||
| Q4 24 | -964.2% | -626.0% | ||
| Q3 24 | -1055.5% | -390.6% | ||
| Q2 24 | -1127.6% | -373.1% | ||
| Q1 24 | -1060.1% | -153.1% |
| Q4 25 | — | $-0.16 | ||
| Q3 25 | $-0.10 | $-0.26 | ||
| Q2 25 | $-0.08 | $-0.17 | ||
| Q1 25 | $-0.52 | $-0.06 | ||
| Q4 24 | $-0.17 | $-0.52 | ||
| Q3 24 | $-0.25 | $-0.33 | ||
| Q2 24 | $-0.23 | $-0.25 | ||
| Q1 24 | $-0.40 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $47.3M | — |
| Total DebtLower is stronger | — | $6.3M |
| Stockholders' EquityBook value | $25.8M | $4.7M |
| Total Assets | $53.2M | $32.7M |
| Debt / EquityLower = less leverage | — | 1.34× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $47.3M | — | ||
| Q2 25 | $31.1M | — | ||
| Q1 25 | $25.2M | — | ||
| Q4 24 | $22.4M | — | ||
| Q3 24 | $14.5M | — | ||
| Q2 24 | $24.9M | — | ||
| Q1 24 | $24.8M | — |
| Q4 25 | — | $6.3M | ||
| Q3 25 | — | $6.2M | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | — | $4.6M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | — | $3.4M | ||
| Q2 24 | — | $3.2M | ||
| Q1 24 | — | $3.2M |
| Q4 25 | — | $4.7M | ||
| Q3 25 | $25.8M | $-336.0K | ||
| Q2 25 | $7.9M | $425.0K | ||
| Q1 25 | $-5.4M | $342.0K | ||
| Q4 24 | $5.4M | $-3.0M | ||
| Q3 24 | $6.3M | $5.5M | ||
| Q2 24 | $16.0M | $8.5M | ||
| Q1 24 | $11.9M | $4.2M |
| Q4 25 | — | $32.7M | ||
| Q3 25 | $53.2M | $37.1M | ||
| Q2 25 | $38.7M | $34.6M | ||
| Q1 25 | $32.8M | $36.5M | ||
| Q4 24 | $30.7M | $37.3M | ||
| Q3 24 | $22.6M | $39.1M | ||
| Q2 24 | $34.1M | $41.3M | ||
| Q1 24 | $32.0M | $29.5M |
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 10.26× | ||
| Q1 25 | — | 13.44× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.62× | ||
| Q2 24 | — | 0.38× | ||
| Q1 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.9M | $-4.8M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-4.8M | ||
| Q3 25 | $-10.9M | $-4.5M | ||
| Q2 25 | $-10.5M | $-4.1M | ||
| Q1 25 | $-12.5M | $-586.0K | ||
| Q4 24 | $-9.9M | $-930.0K | ||
| Q3 24 | $-10.2M | $-3.6M | ||
| Q2 24 | $-11.5M | $-3.1M | ||
| Q1 24 | $-12.6M | $-8.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-4.6M | ||
| Q2 24 | — | $-3.1M | ||
| Q1 24 | — | $-9.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -157.1% | ||
| Q2 24 | — | -151.8% | ||
| Q1 24 | — | -794.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 34.5% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | 87.3% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LUCD
Segment breakdown not available.
MOBX
| US | $1.7M | 92% |
| Other | $155.0K | 8% |
